Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01703065
Title Cabozantinib in Treating Men With Castration-Resistant Prostate Cancer
Recruitment Terminated
Gender male
Phase Phase I
Variant Requirements No
Sponsors University of Washington
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Seattle Cancer Care Alliance/University of Washington Seattle Washington 98109 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field